Effects of High Dose Atorvastatin in Patients With Surgical Aortic Stenosis

• Status: Unknown status
• Trial end date: 2018-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to see if statin therapy will optimize myocardial response to cardiopulmonary bypass during aortic valve replacement (AVR) for aortic valve stenosis (AVS) (Phase I) and optimize left ventricular reverse remodeling following AVR (Phase II). Preliminary evidence indicates that perioperative statin therapy reduce mortality and morbidity following cardiac surgery. Pleiotropic effects of statins may induce myocardial preconditioning and optimize myocardial and systemic responses to cardiopulmonary bypass during AVR. Furthermore statin therapy after AVR may contribute to an optimal left ventricular reverse remodeling.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Strasbourg, France
• Treatments: Atorvastatin; Atorvastatin Calcium

Criteria

Inclusion Criteria:

• Age > or = 70 years and < 80 years

• Severe aortic valve stenosis

• Indication for aortic valve replacement by bioprothesis

• Ejection fraction > or = 50%

• Without treatment with statin- No renal failure

• Informed consent signed

Exclusion Criteria:

• Ischemic heart disaese

• Concomitant surgery to aortic valve replacement

• Emergency surgery- Known intolerance for statin

• Pregnant woman